A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2010
At a glance
- Drugs GS 9411 (Primary)
- Indications Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis
- Focus Adverse reactions
- 11 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 11 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2010 Planned end date changed from Dec 2009 to Feb 2010 as reported by ClinicalTrials.gov.